New cancer drug copycat tested on healthy volunteers
NCT ID NCT07299955
Summary
This is an early, first-in-human study to see how a new, similar version of the cancer drug Herceptin Hylecta (called Bmab3000) behaves in the body. It will involve 150 healthy male volunteers who will receive a single injection and be monitored for about four months. The main goal is to compare how the two drugs are processed by the body and to check for safety and immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.